Both in Biotechnology
Scholar Rock Holding vs CG Oncology
Over the past year SRRK returned +64.3% and CGON returned +73.3%; their daily moves had a correlation of 0.43.
SRRK +64.3% CGON +73.3%Growth of $1, one year, split-adjusted
| Metric | SRRK | CGON |
|---|---|---|
| Price | $46.09 | $67.71 |
| Market cap | $5.61B | $6.00B |
| Today | +4.80% | +5.70% |
| 1 month | +8.6% | +6.4% |
| 6 months | −2.2% | −0.4% |
| Year to date | +4.6% | +63.1% |
| 1 year | +60.1% | +61.6% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | −239.2% |
| Net margin | — | −6832.8% |
| P/E (TTM) | — | — |
| Price / sales | — | 963.7× |
| Net cash | $295.9M | $1.03B |
| Dividend yield | — | — |
| Volatility (60d) | 44.8% | 43.2% |
| Short % of float | 20.3% | 12.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).